New study examines non‐medical use of anti-anxiety medication

There is concern about the misuse of the sedative anti-anxiety medication alprazolam (Xanax®) because of the "high" it can create. A new British Journal of Clinical Pharmacology study found that non-medical use of alprazolam in the United Kingdom is a significant issue, and it appears to be more prevalent in younger adults.

The study examined results from a survey that included 10,019 adults in the United Kingdom. The estimated national prevalence of lifetime non-medical use of alprazolam was 0.32%, and 1.30% for diazepam (valium), another anti-anxiety medication. The prevalence of non-medical use in the last 90 days was significantly different when split by age category for alprazolam, but not for diazepam, with alprazolam non-medical use being more common among younger adults.

The authors noted that most individuals taking alprazolam for non-medical reasons are doing so without a prescription and therefore are unlikely to obtain medical advice before use.

"Further research is urgently needed to further explore the motivations for and appeal of alprazolam for non-medical use among young adults," they wrote. "This will enable appropriate public health interventions to prevent short-term toxicity and long-term dependence among young adults who are regularly using alprazolam."

Source:
Journal reference:

Hockenhull, J. et al. (2019) Non‐medical use of alprazolam in the United Kingdom: results from a nationally representative survey. British Journal of Clinical Pharmacology. doi.org/10.1111/bcp.13959.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hybrid cognitive behavioral therapy shows lasting benefits for pediatric anxiety and OCD